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Abstract. More than half of all young children and pregnant women are affected by anemia. Although its etiology
is multi-factorial, malaria is likely to be a major contributor to chronic anemia in endemic areas. Recent reviews have
examined the effect of community-based malaria control interventions on anemia. We analyze how the prevalence of
anemia depends on that of Plasmodium falciparum malaria by developing models of the excess risk of anemia caused
by malaria at a population level in 24 villages in northeastern Tanzania. In that setting, we estimated that the prevalence
of a hemoglobin level < 8 g/dL attributable to malaria was 4.6% in infants, 4.1% in children one year of age, 2.7% in
children two years of age, and 3.3% in women of childbearing age. Successful validation of our models in other
malaria-endemic settings would enable their use for predicting the impact of malaria control interventions on anemia,
and for long-term monitoring and surveillance of malaria.
INTRODUCTION
The etiology of anemia is usually multi-factorial. In the
developing world, a host of factors play a role, most notably
micronutrient deficiencies (especially iron deficiency), para-
sitic infections (particularly malaria and intestinal nematodes
such as hookworms), infection with human immunodeficiency
virus (HIV), chronic inflammatory disorders, and hemoglo-
binopathies.1–6 Recent literature reviews have established the
causal relationship between malaria and anemia. Community-
based malaria control interventions, including antimalarial
chemoprophylaxis, use of insecticide-treated nets (ITNs), and
indoor residual spraying, consistently improved anemia-
related outcomes in young children.7,8 Therefore, Roll Back
Malaria is considering the use of anemia as an additional
indicator for measuring the impact of the introduction and/or
scaling up of malaria control interventions.8 These include
ITNs,9,10 routine intermittent presumptive treatment of in-
fants11 and a malaria vaccine12 distributed alongside the ex-
panded program on immunization. However, there remain
gaps in our knowledge about the association between malaria
and anemia. Quantification of this association, and its rela-
tionship with age, would enable an enhanced understanding
of the impact of malaria control interventions on the burden
of anemia.
The purpose of this report is to examine how the preva-
lence of chronic anemia depends on that of Plasmodium fal-
ciparum malaria. Parasite and anemia prevalence data, mea-
sured in community-based surveys in northeastern Tanza-
nia,13 were summarized by age group and village. We fitted a
statistical model to predict the excess risk of anemia for each
sub-group as a function of the prevalence of P. falciparum in
that group. We consider the implications for estimates of the
burden of chronic anemia attributable to P. falciparum ma-
laria, and propose that our model, after successful validation
in other settings, can be used for predicting the impact of
malaria control interventions on anemia.
MATERIALS AND METHODS
Study area and population surveyed. Cross-sectional sur-
veys were carried out in October–November 2001 and April–
June 2002 in 24 villages representing 6 altitudinal transects
across northeastern Tanzania. In children less than 15 years of
age, the prevalence of stunting (height-for-age Z-score < −2)
was 40.3% and the prevalence of wasting (weight-for-age Z-
score < −2) was 6.8%. The prevalence of alpha thalassemia
ranged between 4% and 59%, and the prevalence of sickle
cell anemia ranged between 0% and 16%. Both of these he-
moglobinopathies appeared to be correlated with altitude and
the prevalence of malaria (Drakeley CJ, unpublished data),
and alpha thalassemia heterozygotes appeared to have lower
hemoglobin (Hb) levels (Enevold A, unpublished data). The
prevalence of a deficiency in glucose-6-phosphate dehydro-
genase was approximately 7%.14 The prevalence of HIV is
thought to be 6–7% (Mbatia R, unpublished data). Details of
the population surveyed and the field and laboratory tech-
niques used have been presented elsewhere.13,15 Briefly, in
each village an age-stratified sample of approximately 250
persons (< 5 years, 5–14 years, and 15–45 years of age) was
recruited. Blood samples were collected from each individual
and analyzed for the presence and density of malaria parasites
using a standard, quality-controlled light microscopy tech-
nique. Hemoglobin levels were measured by standard hemo-
photometry (HemoCue, Ängleholm, Sweden).
Statistical methods. The parasitemia and anemia data were
summarized within each survey and village by age-group, us-
ing one-year age groups up to four years and five-year age
groups thereafter, leading to a total of 606 sub-groups. For the
main analysis, we excluded the data of women 15–45 years of
age, among whom anemia is specifically associated with men-
struation and pregnancy, and carried out a separate analysis
for these women. The prevalence of anemia, as a function of
parasite prevalence, density, age group, and village, was ana-
lyzed using random effects logistic regression, with the full
model of the form
logitpAa,i,s = a0 + fa,ppa,i,s + sIss + i, (1)
where pA(a,i,s) is the probability of being anemic in group
with age-midpoint a, village i, and survey s, pP(a,i,s) is the
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corresponding parasite prevalence, a0 is the intercept, s the
regression coefficient for the survey effect where Is(s) is an
indicator variable taking the value 0 for the first survey, and
1 for the second, and i is a random effect corresponding to
village i. The observed number of anemic individuals, i.e.,
rA(a,i,s), of nA(a,i,s) individuals tested, was then assumed bi-
nomially distributed
rAa,i,s ∼ BinomialnAa,i,s,pAa,i,s (2)
rp(a,i,s), the observed number of parasitemic individuals (of
np(a,i,s) tested) was also assumed binomially distributed, i.e.,
rPa,i,s ∼ BinomialnPa,i,s,pPa,i,s (3)
Functions f( ) of the forms:
fa, pPa,i,s = a1 lna +
PpPa,i,s
p* + pPa,i,s
(4)
and
fa, pPa,i,s =
a1a*
a* + a
+
PpPa,i,s
p* + pPa,i,s
(5)
were evaluated, as were models including age-prevalence in-
teraction terms. The use of sigmoidal functions on the logit
scale enabled us to constrain the prevalence of anemia to vary
monotonically with age and with parasite prevalence, while
allowing for more possible shapes of curves than would a
linear logistic model. The parameter a* corresponds to the
age at which 50% of the maximal age effect is observed, and
p* to the parasite prevalence corresponding to 50% of the
maximal parasitemia effect. In addition, models were assessed
that included terms in the average parasite density for each
sub-group.
The models were fitted using a Bayesian Markov chain
Monte Carlo algorithm in the software package Winbugs ver-
sion 1.416 with the i assumed normally distributed (centered
on 0), and appropriate imprecise priors were assigned for the
other parameters. Model fit was assessed using the deviance
information criterion (DIC), with lower DICs indicating im-
proved fits.17
The full model contained all the terms we considered for
inclusion. Because we required a model that could be applied
to general situations, not just to the two surveys that we car-
ried out, we also considered a model without terms in the
survey (the reference model), i.e.,
logitpAa,i,s = a0 + fa, pPa,i,s + i (6)
This was compared with simpler models from which addi-
tional terms were removed if they did not improve the fit.
The excess risk of anemia, RA(a,i,s), is estimated by the
difference between the actual prediction and the prediction
that would be made for the same age group, survey, and
village at zero prevalence, i.e., in the case of the reference
model
RAa,i,s = pAa,i,s −
1
1 + exp−a0 + fa,0 + i
(7)
We compute point and interval estimates for RA(a,i,s) by
sampling from the posterior distribution implied by equa-
tion 7.
We carried out a separate analysis of anemia in women of
childbearing age (i.e., 15–45 years) based on the assumption
that pregnancy-associated anemia and malaria account for the
higher prevalence in women than in men in this age group.
Since there is little age-dependence in the anemia or parasit-
emia rates in adults, this analysis considered how the anemia
prevalence in women of childbearing age compares with that
in men, and how this is related to the overall parasite preva-
lence in the group defined at the level of survey within village.
This was estimated using an additive model, i.e., we assume
that
rfi,s ∼ Binomialnfi,s, pfi,s (8)
where rf(i, s) is the number of anemic women among nf(i,s)
sampled in village i, survey s and
pfi,s = pmi,s + 1 − pmi,spf0 + 1 − pf0 mpPi,s1 + mpPi,s
(9)
where pm(i,s) is the corresponding prevalence in men; pf0 is
the excess risk of anemia in women in the absence of P.
falciparum (we assume this is pregnancy-related, but not ma-
laria-associated); pp(,i,s) is the overall prevalence of P. falci-
parum in adults in village i, survey s; and m is then a coef-
ficient quantifying the strength of the relationship between
parasite prevalence and malaria attributable excess of anemia
in women of childbearing age.
RESULTS
The overall prevalence of anemia (Hb levels < 8 g/dL and
< 11 g/dL) was strongly related both to the age of the host and
to the parasite prevalence (Figure 1). In both cases the ane-
mia and parasite prevalence were slightly higher at the second
survey during the long rain season than at the first survey
during the dry season (Table 1).13
Terms in age and parasite prevalence were both needed to
give adequate predictions of the levels of anemia. The age
effect on the prevalence of anemia could not be accounted for
by the parasite prevalence alone, even when higher order
terms in pp(a,i,s) were introduced into the model, nor could
the prevalence effect be explained by age alone. Introducing
a term for parasite density did not result in improved model
fit, as measured by the DIC.
Testing of different forms of age dependence indicated that
the main effect of age was best modeled with a sigmoidal
function (equation 5). However, there was an interaction be-
tween the effect of age and parasitemia, with the best fit
achieved by using a logarithmic transformation of age (equa-
tion 10). Models including interactions with sigmoidal func-
tions of age were poorly identifiable and were therefore re-
jected in favor of the reference model (ii in Table 2) (equation
10).
logitpAa,i,s = 0 +
a1a*
a* + a
+
ppPa,i,s
p* + pPa,i,s
+ 1pPa,i,s loga + i (10)
The fit of the model was only improved slightly by including
terms in the survey (compare models i and ii in Table 2),
indicating that the between-survey variation in anemia was
largely explained by the variation in parasite prevalence be-
tween survey periods.
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We assumed the same relationships of anemia with age and
parasite prevalence in all villages, but there was substantial
variation between villages in anemia levels even after allow-
ance for the differences in prevalence (compare models ii and
iii in Table 2). The best fitting models therefore also included
the random effect terms allowing for differences between vil-
lages in anemia prevalence. For the model that we plan to
generalize to other settings, we use estimates based on the
reference model ii but without terms in the survey and with
i  0 (i.e., no village-level random effect). The parameter
estimates for this model are given in Table 3.
We used model ii to estimate fitted values of the moderate
anemia prevalence (Hb level < 8 g/dL) for each of the 606
sub-groups (Figure 1a and b). Although the age pattern of
these predictions showed the expected decrease with age, the
predicted anemia prevalence did not increase smoothly with
parasite prevalence measured at the level of the group. This
was because of the low number of villages with high parasite
prevalence.
The fitted values of anemia prevalence (Hb levels < 8 g/dL
and < 11 g/dL) estimated for a hypothetical village with i 
0 showed the expected smooth patterns of decrease with age
(Figure 2) and increase with parasitemia. A fraction of this
anemia will be due to causes other than malaria. For this
reason, we computed the excess risk associated with parasit-
emia by subtracting the estimated levels in the absence of
TABLE 1
Unadjusted estimates of anemia and parasitemia*
Group
(age, years) Survey
No. of
individuals
Prevalence of
Hb < 11 g/DL
Prevalence of
Hb < 8 g/dL
Prevalence
of patent
Plasmodium
falciparum
parasitemia
Children 1 3,710 34.6% 2.6% 16.9%
(0–14) 2 3,627 35.0% 3.7% 23.5%
Men 1 609 7.7% 2.0% 11.9%
(15–45) 2 589 9.7% 1.4% 14.8%
Women 1 1,454 24.1% 4.7% 11.5%
(15–45) 2 1,443 25.8% 3.6% 17.3%
* Hb  hemoglobin.
FIGURE 1. Prevalence and excess risk of hemoglobin (HB) levels < 8 g/dL and < 11 g/dL. a, Prevalence and excess risk of an Hb level < 8 g/dL
by age. b, Prevalence and excess risk of an Hb level < 8 g/dL by Plasmodium falciparum prevalence. c, Prevalence and excess risk of an Hb level
< 11 g/dL by age. d, Prevalence and excess risk of an Hb level < 11 g/dL by P. falciparum prevalence. Points indicate the data (including adult
women). The upper line shows the fitted prevalence from model ii equation 10 (excluding adult women) and the lower line shows the estimate
of excess risk attributable to P. falciparum malaria.
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parasites from our estimates of anemia prevalence (Figure 3).
The major impact of malaria on anemia in children has pre-
viously been shown to occur in children less than 2–3 years of
age8,18 and a similar age-related pattern was seen here. At the
average levels of endemicity in the study area we estimated
the prevalence of an Hb level < 8 g/dL attributable to malaria
to be 4.6% in the first year of life, 4.1% and 2.7% in children
1 and 2 years of age, respectively, which decreased to 0.8% in
the 5–9-year-old age group and to approximately 0.1% in
adult males.
We fitted an equivalent model to that of equation 10 to
predict the prevalence of an Hb level < 11 g/dL. This showed
an excellent fit to the age-prevalence relationship (Figure 1c)
and to the relationship with prevalence of parasites (Figure
1d).
Unlike an Hb level < 8 g/dL, a level <11 g/dL is frequent
even at very low levels of parasite prevalence. Thus, the pro-
portion attributable to malaria is much lower than that for an
Hb level < 8 g/dL. This is especially the case in the youngest
children among whom the estimates of the excess risk of an
Hb level < 11 g/dL did not increase monotonically with age at
any given prevalence of parasitemia. This is because the es-
timated prevalence of an Hb level < 11 g/dL in the absence of
parasitemia is so high in the youngest children that there is
little scope for an increase. The excess risk thus reaches a
maximum in older children, when the baseline parasitemia
has already decreased (Figure 3c).
The prevalence of Hb levels < 8 g/dL and < 11 g/dL in adult
women (15–45 years of age) was much higher than in age-
matched men, and showed strong relationships with parasite
TABLE 2
Comparisons of the fit of the model for prevalence of anemia
Model Linear predictor DIC*
i Full model
(equation 1) 0 +
a1a*
a* + a
+
PpPa, i, s
p* + pPa, i, s
+ a2pPa, i, s lna + sIss + i
768.8
ii Reference model
0 +
a1a*
a* + a
+
PpPa, i, s
p* + pPa, i, s
+ a2pPa, i, s lna + i
769.5
iii Reference model
without village
effect
0 +
a1a*
a* + a
+
PpPa, i, s
p* + pPa, i, s
+ a2pPa, i, s lna
796.1
iv Reference model
without age-
parasitemia
interaction
0 +
a1a*
a* + a
+
PpPa, i, s
p* + pPa, i, s
+ i
771.9
v Reference model
with different
parameterization
of age effect
a0 +
PpPa, i, s
p* + pPa, i, s
+ a1 + a2pPa, i, s lna + i
778.4
* The figures given are for the fit of the model to the anemia prevalence data. A good fit
is indicated by a low value of the deviance information criterion (DIC).
TABLE 3
Parameter estimates from the best-fitting model*
Parameter description
Estimates from model† for Hb < 11 g/dL Estimates from model for Hb < 8 g/dL
Mean 2.5% 97.5% Mean 2.5% 97.5%
0 Intercept −4.62 −5.19 −4.13 −6.13 −7.19 −5.19
P Effect of parasite prevalence 8.08 1.51 21.7 12.5 4.39 25.6
p* Critical value of parasite prevalence 6.52 3.74 25.0 2.84 0.59 7.03
a1 Magnitude of age effect (/year) 6.36 5.86 6.91 3.14 1.92 4.42
a* Critical age (years) 4.70 3.81 5.69 3.66 1.75 6.51
1 Age-prevalence inter-action effect 0.50 0.13 0.90 −0.75 −1.52 −0.04
* Hb.
† Calculated from the percentiles of > 10,000 samples from the posterior distributions, using a model corresponding to equation 10.
FIGURE 2. Model predictions of the prevalence of hemoglobin
(Hb) levels < 8 g/dL and < 11 g/dL. a, Prevalence of an Hb level < 8
g/dL by age. b, Prevalence of an Hb level < 11 g/dL by age. The
predictions correspond to the fitted values from model ii equation 10
at i  0. The lower lines correspond to the lowest parasite preva-
lence (10%). The remaining lines correspond to predictions at 10%
increments in parasitemia.
ESTIMATING THE MALARIA ATTRIBUTABLE RISK OF ANEMIA 85
prevalence (Figure 4). These relationships were captured by
the additive binomial models (equation 9), which showed a
good fit to both outcomes (Figure 5). The excess risk of an Hb
level < 8 g/dL in adult women compared with men in the
absence of P. falciparum was estimated to be 1.3% and that of
an Hb level < 11 g/dL was estimated to be 6.1% (Table 4).
Both of these percentages were estimated to strongly increase
with parasite prevalence (Figure 5), so that at the average P.
falciparum prevalence of 14.4% (Table 1), the difference in
risk of an Hb level < 8 g/dL between men and women is 3.3%
and of an Hb level < 11 g/dL is as high as 19.1%. Although
only women are susceptible to the effects of malaria infection
during pregnancy, both pregnancy and menstruation impact
anemia independently of any effects of malaria. At the aver-
age P. falciparum prevalence of 14.4%, 66% of the Hb levels
< 8 g/dL in these women can be attributed to malaria expo-
sure, which corresponds to a prevalence of malaria-
attributable anemia among women 15–45 years of age of
3.3%.
DISCUSSION
The within-host dynamics of malaria anemia are complex,
even in the non-immune host.19 Underlying reasons include
malaria infection resulting in destruction of non-parasitized
erythrocytes and diserythropoeisis,19,20 direct destruction of
parasitized erythrocytes,21,22 and multiple genetic factors.3,4
Thus, anemia secondary to P. falciparum infection can result
from a long series of events. The parasitologic status of the
FIGURE 3. Model predictions of excess risk of hemoglobin (Hb) levels < 8 g/dL and < 11 g/dL. a, Excess risk of an Hb level < 8 g/dL by age.
b, Excess risk of an Hb level < 8 g/dL by Plasmodium falciparum prevalence. c, Excess risk of an Hb level < 11 g/dL by age. d, Excess risk of an
Hb level < 11 g/dL by P. falciparum prevalence. The predictions correspond to the fitted values from model ii equations 7 and 10 at i  0. The
lower lines in figures a and c correspond to the lowest parasite prevalence (10%). The remaining lines correspond to predictions at 10%
increments in parasitemia. The upper line in b corresponds to the midpoint of the youngest age group analyzed (< 1 year of age) and the other
lines in order to the age groups 1, 2, 3, 4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34, 35–39, and 40–44 years of age at the last birthday. The lines are
ranked in the same order at the left hand side of d, but the lack of monotonicity in c results in lines crossing in the right hand part of figure d.
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host at the time of sampling may be a poor indicator of wheth-
er the anemia is mainly due to malaria, rather than nutritional
deficiencies, concomitant infections, chronic inflammatory re-
sponses, or a combination of etiologic factors.
It is usually appropriate to assess epidemiologic exposures
at the level of the individual. Assignment of group-level ex-
posure measurements to individuals can lead to misclassifica-
tion and to biased estimates of exposure-response relation-
ships. However, the recent history of parasitization may be a
better predictor of anemia than the level or presence of con-
current parasitemia.23 In a situation where infections are con-
tinually turning over in the population, the prevalence at vil-
lage level represents a reasonable estimate of recent exposure
of the individual, and this justifies the use of population level
estimates of the burden of parasitism as one approach to
predict malaria-associated anemia.
We were not able to predict the age distribution of anemia
from either the parasite densities or parasite prevalence data
alone. This indicates either age-dependence in other risk fac-
tors for anemia, or age-dependence in the vulnerability of the
human host to the parasitologic insult as a result of acquired
partial immunity, or a combination of these two factors. In
malaria-endemic settings of sub-Saharan Africa, age patterns
of anemia show a peak between 1 and 1.5 years.6 Importantly,
the effect of malaria parasitemia on anemia has been shown
to decrease with age.18 By including the age-parasitemia in-
teraction term in our model, we hoped to capture this phe-
nomenon. The dependence of our model on the logarithm of
the age is potentially inconvenient if it is used to estimate
anemia rates for very young babies, but we do not claim
validity for the model in the youngest children, since the dy-
namics of Hb and erythropoiesis in the first few months of life
are very different from those later in life.
Estimates of the global burden of P. falciparum malaria
generally only include direct effects such as clinically relevant
malaria fevers, cerebral malaria, severe malaria anemia, and
death, with the latter accounting for the bulk of the bur-
den.24–26 Inclusion of chronic anemia as an indirect effect of
malaria infection is usually avoided because of the complexity
of attributing the anemia to malaria. We have attempted to
quantify the prevalence of malaria-related chronic anemia
(Hb levels < 11 g/dL and < 8 g/dL) by modeling the excess risk
of anemia due to malaria at a population level.
TABLE 4
Parameter estimates from model for anemia in adult women (15–45
years of age)*
Parameter
Estimates from model
for Hb < 11 g/dL
Estimates from model
for Hb < 8 g/dL
Mean 2.5% 97.5% Mean 2.5% 97.5%
pf0 0.061 0.04 0.083 0.013 0.006 0.022
m 1.12 0.86 1.38 0.14 0.070 0.21
* Hb  hemoglobin; pf0  excess risk of anemia in women (compared to men) in the
absence of Plasmodium falciparum; m  increase in risk with prevalence of P. falciparum.
FIGURE 4. Prevalence of hemoglobin (Hb) levels < 8 g/dL and
< 11 g/dL in men and women. a, Observed prevalence of an Hb level
< 8 g/dL. b, Observed prevalence of an Hb level < 11 g/dL The upper
points represent the data for women and the lower points represent
data for men. The lengths of the vertical lines joining the points
correspond to the risk difference.
FIGURE 5. Excess risk of hemoglobin (HB) levels < 8 g/dL and
< 11 g/dL in adult women. a, Excess risk of an Hb level < 8 g/dL. b,
Excess risk of an Hb level < 11 g/dL. –––  model predictions;  
observed risk difference.
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Our estimates suggest that in the epidemiologic setting of
northeastern Tanzania where most villages surveyed were
mesoendemic for malaria (i.e., parasite prevalence in children
0–4 years of age < 50%), more than 4% of children less than
three years of age, and 3.3% of women of childbearing age,
who bear the brunt of malaria disease, are affected by ma-
laria-attributable Hb levels < 8 g/dL. The present analyses
provide estimates of the prevalence of maternal anemia
within the whole population of women of childbearing age
without the need to consider what proportion of women are
pregnant at any one time, or whether there are differences
between primigravidae and multigravidae, although these dif-
ferences have been documented. The contribution of malarial
anemia during pregnancy is generally considered to be very
important, resulting in impaired fetal development, prema-
ture delivery, low birth weight, maternal and infant anemia,
and infant mortality.27,28
The study area was selected specifically to include a wide
range of malaria transmission intensities,13,15 and therefore
provides an average estimate of the proportion of anemia due
to malaria in endemic areas. Further investigations in this
area support the finding of a high excess risk of anemia due to
malaria in very young children.29 The models presented here
enable us to estimate the burden of malaria-related anemia at
any given population prevalence, and can also be used to
assess the potential impact on chronic anemia of different
malaria intervention efforts.7,8
It is interesting to note that peak anemia prevalence seems
to be closely linked to the age of admission for severe anemia
in hospitals in the same study area.30 Although there is no
clear link between moderate anemia and mortality,31 there is
evidence that anemia can have substantial effects on cognitive
and motor development and on growth.32,33 It has also been
hypothesized that anemia may be associated with impaired
immunity and consequently increased susceptibility to infec-
tious disease.34 In this way, anemia, as an indirect effect of
malaria may contribute to the malaria gap, i.e., the gap be-
tween the socioeconomic impact of the disease that can be
documented in microeconomic studies, and the massive im-
pact that is implied by macroeconomic studies using cross-
country regression analyses that compare malaria-free coun-
tries with those where the disease is highly endemic.35
It is therefore essential that estimates of malaria burden
and evaluation of malaria interventions include the contribu-
tion of malaria to chronic anemia in the community. The
models presented here enabled us to attribute a proportion of
anemia to malaria in different age groups in northeastern
Tanzania. Successful validation of the models in a range of
settings across Africa, where the bulk of the malaria burden is
currently concentrated, will allow prediction of the impact of
different malaria interventions, including the introduction of
malaria vaccines, under different transmission intensity sce-
narios.
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